Tingyan Shi

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

Tingyan Shi, Jianqing Zhu, Yanling Feng et al. · The Lancet Oncology · 2021 · 227 citations

Medicine, Gynecology, Oncology +16

The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells

Zhiyuan Hu, Mara Artibani, Abdulkhaliq Alsaadi et al. · Cancer Cell · 2020 · 215 citations · Full text

Medicine, Gynecology, Oncology +16

Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women

Kexin Chen, Hongxia Ma, Rongyu Zang et al. · Nature Communications · 2014 · 78 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

<i>BRCA1</i> and <i>BRCA2</i> mutations in ovarian cancer patients from China: ethnic‐related mutations in <i>BRCA1</i> associated with an increased risk of ovarian cancer

Tingyan Shi, Pan Wang, Caixia Xie et al. · International Journal of Cancer · 2017 · 61 citations · Full text

Medicine, Genetics, Oncology +17

Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma

Chenguang Li, Zhibo Gao, Fei Li et al. · Scientific Reports · 2015 · 55 citations · Full text

Medicine, Genetics, Oncology +17